Skip to main content

Advertisement

SpringerLink
Log in

High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

We aimed to evaluate the association of preoperative plasma fibrinogen levels with the clinicopathological parameters, disease-free survival, and overall survival in patients with renal cell carcinoma.

Methods

We retrospectively studied 286 patients with renal cell carcinoma who underwent radical nephrectomy from 2000 to 2003 at one center. The plasma fibrinogen was routinely determined before operation in all patients. The correlation of preoperative plasma fibrinogen levels with clinicopathological findings was evaluated by t-test or analysis of variance (ANOVA) methods. As well, univariate and multivariate analyses were used to determine the association between the preoperative level of plasma fibrinogen and survival duration.

Results

An elevated level of plasma fibrinogen was positively related to the Fuhrman grade (P < 0.001), tumor size (P < 0.001), and T stage (P < 0.001), but it was negatively related to histologic type (P = 0.266). Univariate analysis showed that the Fuhrman grade, tumor size, T stage, hemoglobin, corrected calcium, lactate dehydrogenase, and plasma fibrinogen level were significantly correlated with disease-free survival (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P = 0.001, P < 0.001, and P < 0.001, respectively) and overall survival (P < 0.001, P = 0.001, P < 0.001, P < 0.001, P = 0.002, P = 0.001, and P < 0.001). Multivariate analysis showed that the plasma fibrinogen level remained as an independent prognostic factor for disease-free survival (P = 0.021) and overall survival (P < 0.001).

Conclusions

A high preoperative plasma fibrinogen level is an independent predictor of distant metastasis and survival prognosis after radical nephrectomy in patients with renal cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

RCC:

Renal cell carcinoma

DFS:

Disease-free survival

OS:

Overall survival

CRP:

C-reactive protein

LDH:

Lactate dehydrogenase

References

  1. Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31

    PubMed  CAS  Google Scholar 

  2. Wang X, Wang E, Kavanagh JJ et al (2005) Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3:25

    Article  PubMed  CAS  Google Scholar 

  3. Bardos H, Molnar P, Csecsei G et al (1996) Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul Fibrinolysis 7:536–548

    Article  PubMed  CAS  Google Scholar 

  4. Dvorak HF, Nagy JA, Berse B et al (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci 667:101–111

    Article  PubMed  CAS  Google Scholar 

  5. Tennent GA, Brennan SO, Stangou AJ et al (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109:1971–1974

    Article  PubMed  CAS  Google Scholar 

  6. Collen D, Tytgat GN, Claeys H et al (1972) Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Br J Haematol 22:681–700

    Article  PubMed  CAS  Google Scholar 

  7. Koenig W (2003) Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 89:601–609

    PubMed  CAS  Google Scholar 

  8. Altieri DC, Mannucci PM, Capitanio AM (1986) Binding of fibrinogen to human monocytes. J Clin Invest 78:968–976

    Article  PubMed  CAS  Google Scholar 

  9. Dejana E, Languino LR, Polentarutti N et al (1985) Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 75:11–18

    Article  PubMed  CAS  Google Scholar 

  10. Dvorak HF, Harvey VS, Estrella P et al (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57:673–686

    PubMed  CAS  Google Scholar 

  11. Gross TJ, Leavell KJ, Peterson MW (1997) CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 77:894–900

    PubMed  CAS  Google Scholar 

  12. Languino LR, Duperray A, Joganic KJ et al (1995) Regulation of leukocyte–endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 92:1505–1509

    Article  PubMed  CAS  Google Scholar 

  13. Robson SC, Saunders R, Purves LR et al (1993) Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood 81:3006–3014

    PubMed  CAS  Google Scholar 

  14. Gerner C, Steinkellner W, Holzmann K et al (2001) Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis. Thromb Haemost 85:494–501

    PubMed  CAS  Google Scholar 

  15. Palumbo JS, Potter JM, Kaplan LS et al (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62:6966–6972

    PubMed  CAS  Google Scholar 

  16. Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185

    Article  PubMed  CAS  Google Scholar 

  17. Palumbo JS, Kombrinck KW, Drew AF et al (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302–3309

    PubMed  CAS  Google Scholar 

  18. Cavanaugh PG, Sloane BF, Honn KV (1988) Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. Haemostasis 18:37–46

    PubMed  CAS  Google Scholar 

  19. Chew EC, Wallace AC (1976) Demonstration of fibrin in early stages of experimental metastases. Cancer Res 36:1904–1909

    PubMed  CAS  Google Scholar 

  20. Crissman JD, Hatfield JS, Menter DG et al (1988) Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48:4065–4072

    PubMed  CAS  Google Scholar 

  21. Hatzfeld JA, Hatzfeld A, Maigne J (1982) Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA 79:6280–6284

    Article  PubMed  CAS  Google Scholar 

  22. Pollanen J, Stephens RW, Vaheri A (1991) Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273–328

    Article  PubMed  CAS  Google Scholar 

  23. Yamashita H, Kitayama J, Kanno N et al (2006) Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6:147

    Article  PubMed  Google Scholar 

  24. Polterauer S, Seebacher V, Hefler-Frischmuth K et al (2009) Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer. Am J Obstet Gynecol 200(647):e641–e647

    Google Scholar 

  25. Polterauer S, Grimm C, Seebacher V et al (2009) Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 14:979–985

    Article  PubMed  Google Scholar 

  26. Lopez Y, Paloma MJ, Rifon J et al (1999) Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 93:71–78

    Article  PubMed  CAS  Google Scholar 

  27. Kerlin B, Cooley BC, Isermann BH et al (2004) Cause-effect relation between hyperfibrinogenemia and vascular disease. Blood 103:1728–1734

    Article  PubMed  CAS  Google Scholar 

  28. Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59:1295–1300

    PubMed  CAS  Google Scholar 

  29. Yano HJ, Hatano K, Tsuno N et al (2001) Clustered cancer cells show a distinct adhesion behavior from single cell form under physiological shear conditions. J Exp Clin Cancer Res 20:407–412

    Google Scholar 

  30. Yamashita H, Kitayama J, Nagawa H (2005) Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 35:595–600

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a Grant from the National Natural Science Foundation of China, No. 81072090.

Conflict of interest

We have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Hexi District, Tianjin, 300060, People’s Republic of China

    Jun Du, Jian-Hua Zheng, Xu-Sheng Chen, Qing Yang, Yan-Hui Zhang, Lei Zhou & Xin Yao

Authors
  1. Jun Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian-Hua Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xu-Sheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan-Hui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xin Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xin Yao.

Additional information

J. Du and J.-H. Zheng contributed equally to this work.

About this article

Cite this article

Du, J., Zheng, JH., Chen, XS. et al. High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma. Int J Clin Oncol 18, 517–523 (2013). https://doi.org/10.1007/s10147-012-0412-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-012-0412-x

Keywords

Search

Navigation